弘世貴久 (TAKAHISA HIROSE) - マイポータル

Comparison of the effects of sitagliptin and dapagliflozin on time in range in Japanese patients with type 2 diabetes stratified by body mass index: A sub-analysis of the DIVERSITY-CVR study.

Kota Takuma, Ayako Fuchigami, Fumika Shigiyama, Naoki Kumashiro, Takahisa Hirose

Diabetes, obesity & metabolism 2023年4月12日

SGLT2 inhibitor versus carbohydrate-restricted isocaloric diet: reprogramming substrate oxidation in type 2 diabetes.

Hiroyuki Igarashi, Hiroshi Uchino, Momoko Kanaguchi, Kaori Hisanaga, Genki Sato, Fukumi Yoshikawa, Masashi Furuta, Naohiro Washizawa, Shuki Usui, Masahiko Miyagi …

Diabetology & metabolic syndrome 15(1) 25-25 2023年2月19日

Aldosterone-to-Renin Ratio Is Associated with Diabetic Nephropathy in Type 2 Diabetic Patients: A Single-Center Retrospective Study.

Mariko Higa, Takamasa Ichijo, Takahisa Hirose

Medical science monitor : international medical journal of experimental and clinical research 28 e935615 2022年3月20日

Postprandial Glucose Excursions in Asian Versus Non-Asian Patients with Type 2 Diabetes: A Post Hoc Analysis of Baseline Data from Phase 3 Randomised Controlled Trials of IDegAsp.

Wenying Yang, Shahid Akhtar, Edward Franek, Martin Haluzík, Takahisa Hirose, Balamurali Kalyanam, Soumitra Kar, Ted Wu, Dilek Gogas Yavuz, Ambika Gopalakrishnan Unnikrishnan

Diabetes therapy : research, treatment and education of diabetes and related disorders 13(2) 311-323 2022年2月

Quantitative evaluation of insulin-induced abdominal subcutaneous dystrophic tissue using shear wave elastography.

Genki Sato, Hiroshi Uchino, Yosuke Shimizu, Junko Tatebe, Toshisuke Morita, Takahisa Hirose

Journal of diabetes investigation 13(6) 1004-1010 2022年1月31日

Dipeptidyl peptidase-4 inhibitor improves glycemic variability in multiple daily insulin-treated type 2 diabetes: a prospective randomized-controlled trial.

Fukumi Yoshikawa, Hiroshi Uchino, Tomoko Nagashima, Shuki Usui, Masahiko Miyagi, Yasuyo Ando, Takahisa Hirose

Diabetology international 13(1) 124-131 2022年1月

A Real-World, Prospective, Non-interventional Study of Adults with T2D Switching to IDegAsp from Glargine U100 or U300 in Japan.

Fumika Shigiyama, Lei Liu, Helene Nordahl, Ryo Suzuki, Yuiko Yamamoto, Takahisa Hirose

Diabetes therapy : research, treatment and education of diabetes and related disorders 2021年7月25日査読有り最終著者責任著者

Changes in subjective sleep quality in patients with type 2 diabetes who did not use Sleep agents: a cross‑sectional study according to age and clinical background.

Yoshikawa F, Kumashiro N, Shigiyama F, Miyagi M, Ando Y, Uchino H, Hirose T

Diabetology International 13(1) 142-147 2021年6月査読有り最終著者責任著者

A Real-World, Observational Study of the Initiation, Use, and Effectiveness of Basal-Bolus or Premixed Insulin in Japanese People with Type 2 Diabetes.

Hideaki Miyoshi, Mike Baxter, Takeshi Kimura, Masakatsu Hattori, Yukiko Morimoto, Dion Marinkovich, Masami Tamiwa, Takahisa Hirose

Diabetes therapy : research, treatment and education of diabetes and related disorders 12(5) 1341-1357 2021年5月

Simplification of complex insulin regimens using canagliflozin or liraglutide in patients with well-controlled type 2 diabetes: A 24-week randomized controlled trial.

Yasuyo Ando, Fumika Shigiyama, Takahisa Hirose, Naoki Kumashiro

Journal of diabetes investigation 2021年3月2日

Current state of hypnotic use disorders: Results of a survey using the Japanese version of Benzodiazepine Dependence Self-Report Questionnaire.

Mai Yamamoto, Ken Inada, Minori Enomoto, Mitsunari Habukawa, Takahisa Hirose, Yuichi Inoue, Jun Ishigooka, Yuichi Kamei, Tsuyoshi Kitajima, Masayuki Miyamoto …

Neuropsychopharmacology reports 41(1) 14-25 2021年3月

A prospective randomized study comparing effects of empagliflozin to sitagliptin on cardiac fat accumulation, cardiac function, and cardiac metabolism in patients with early-stage type 2 diabetes: the ASSET study.

Shigenori Hiruma, Fumika Shigiyama, Shinji Hisatake, Sunao Mizumura, Nobuyuki Shiraga, Masaaki Hori, Takanori Ikeda, Takahisa Hirose, Naoki Kumashiro

Cardiovascular diabetology 20(1) 32-32 2021年2月2日

Pre-Existing Diabetes Limits Survival Rate After Immune Checkpoint Inhibitor Treatment for Advanced Lung Cancer: A Retrospective Study in Japan.

Kaori Hisanaga, Hiroshi Uchino, Naoko Kakisu, Masahiko Miyagi, Fukumi Yoshikawa, Genki Sato, Kazutoshi Isobe, Kazuma Kishi, Sakae Homma, Takahisa Hirose

Diabetes, metabolic syndrome and obesity : targets and therapy 14 773-781 2021年

A comparison of meal tolerance test and oral glucose tolerance test for predicting insulin therapy in patients with gestational diabetes.

Mai Hijikata, Mariko Higa, Takamasa Ichijo, Takahisa Hirose

Food & nutrition research 65 2021年

Risk of hypoglycemia in Japanese people with type 2 diabetes mellitus who initiated or switched to insulin glargine 300 U/mL: A subgroup analysis of 12-month post-marketing surveillance study (X-STAR study).

Takahisa Hirose, Masato Odawara, Munehide Matsuhisa, Ryusuke Koshida, Masayuki Senda, Yasushi Tanaka, Yasuo Terauchi

Diabetes research and clinical practice 172 108647-108647 2020年12月24日

Chronotherapeutic efficacy of suvorexant on sleep quality and metabolic parameters in patients with type 2 diabetes and insomnia.

Fukumi Yoshikawa, Fumika Shigiyama, Yasuyo Ando, Masahiko Miyagi, Hiroshi Uchino, Takahisa Hirose, Naoki Kumashiro

Diabetes research and clinical practice 169 108412-108412 2020年9月8日査読有り

Real-world data on the use of insulin glargine 300 U/mL in Japanese patients with type 1 diabetes: twelve-month results from a post-marketing surveillance study (X-STAR study).

Munehide Matsuhisa, Masato Odawara, Takahisa Hirose, Ryusuke Koshida, Masayuki Senda, Yasushi Tanaka, Yasuo Terauchi

Expert opinion on pharmacotherapy 1-8 2020年8月25日査読有り

Role of growth hormone signaling pathways in the development of atherosclerosis.

Mayumi Ishikawa, Junko Toyomura, Takashi Yagi, Koji Kuboki, Toshisuke Morita, Hitoshi Sugihara, Takahisa Hirose, Shiro Minami, Gen Yoshino

Growth Hormone & IGF Research 2020年8月査読有り

Effectiveness and safety of insulin glargine 300 unit/mL in Japanese type 2 diabetes mellitus patients: a 12-month post-marketing surveillance study (X-STAR study).

Masato Odawara, Munehide Matsuhisa, Takahisa Hirose, Ryusuke Koshida, Masayuki Senda, Yasushi Tanaka, Yasuo Terauchi

Expert opinion on pharmacotherapy 1-10 2020年7月22日査読有り

Effectiveness of dapagliflozin on vascular endothelial function and glycemic control in patients with early-stage type 2 diabetes mellitus: DEFENCE study.

Fumika Shigiyama, Naoki Kumashiro, Masahiko Miyagi, Kayoko Ikehara, Eiichiro Kanda, Hiroshi Uchino, Takahisa Hirose

Cardiovascular diabetology 16(1) 84-84 2017年7月6日査読有り

弘世貴久

基本情報

研究分野

論文

メニュー